FDA Inspection 1233599 — New York Cryo

New York Cryo — FEI 3003422359

The FDA completed an inspection of New York Cryo on Mar 21, 2024 in Great Neck, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 21, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Great Neck, NY (United States)

Citations

IDCFRDescription
1222921 CFR 1271.50(a)Determination based on screening and testing